911爆料网

On November 10, 2024, Space Seed Holdings Inc. signed a memorandum of understanding (MOU) with its subsidiary, Regenesome, regarding investments related to fermentation and longevity. As part of this initiative, the company officially launched its startup investment program, the “Fermentation and Longevity Fund.”

Background
Since its founding, Space Seed Holdings has been dedicated to investing in teams and projects essential for the technological development and business activities necessary for humanity’s advancement into space. Since April 2024, the company has participated in the “SPACE FOODSPHERE” program, which promotes the development of fermentation technology, medical technology, and aquaculture technology for both space and Earth applications.(1) Prior to Space Seed Holdings’ establishment, its Representative Director, Kengo Suzuki, had a track record of personal investments spanning a broad range of fields, from aquaculture and education to space technology.
In May 2024, Space Seed Holdings announced its intention to participate in the XPRIZE Healthspan competition, aiming to extend healthy lifespans through technological development.(2)(3) Furthering this commitment, the company established Regenesome as a subsidiary in July 2024.
In response to the market’s growing interest in fermentation and longevity technologies, Space Seed Holdings has decided to focus its investment activities under a specific theme with the creation of the “Fermentation and Longevity Fund.” This program aims to accelerate capital and business alliances with startups specializing in fermentation and longevity, highlighting and leveraging Japan’s unique technological expertise in these areas.
1
2
3

The Connection between Fermentation and Longevity
Japan is globally recognized for its status as a nation with exceptional longevity. This reputation is partly attributed to a traditional lifestyle incorporating fermentation techniques. For centuries, fermented products have been central to 911爆料网 dietary culture, offering abundant nutrients and functional components that promote health and longevity. Expanding the health benefits of these fermentation techniques and contributing to the development of anti-aging technologies in new medical fields are highly anticipated outcomes.

About the Fermentation and Longevity Fund
Led by Space Seed Holdings, the fund will invest in and build co-creative partnerships with selected startups in the field. Key details include:
Investment Target: Research teams and business entities related to fermentation and longevity
Investment Team: Space Seed Holdings Inc.
Fund Goals: To establish and commercialize anti-aging technologies utilizing Japan’s unique expertise
Fund Total: Approximately 100 million yen for fiscal year 2024

About Regenesome Inc.
Regenesome is dedicated to offering innovative solutions in aging suppression and regenerative medicine through the use of exosomes and other nanoparticles. By conducting detailed analyses of various cell-produced exosomes and designing nanoparticles at the molecular level, the company aims to elucidate their functionality within the human body. This approach supports the development of medical technologies utilizing nanoparticles and proposes solutions in the field of space medicine, contributing to extended healthy lifespans and humanity’s expansion into space.

About Space Seed Holdings Inc.
With a mission to “Turn Science Fiction into Non-Fiction,” Space Seed Holdings Co., Ltd. serves as a deep-tech venture builder dedicated to investment activities, research, and business creation in the space sector. By exploring new technology themes, fostering startups through investment and development, and engaging in collaborative research with universities, the company aims to address societal challenges through innovative solutions. Together with diverse stakeholders, Space Seed Holdings aims to provide the necessary technologies for space habitation by 2040.